News

MediLynx Cardiac Monitoring, LLC has received a broad patent for continuous (full-disclosure) ECG streaming, analysis and monitoring from a remote location.

Great Debates & Updates in Electrophysiology (GDU EP), the official meeting of EP Lab Digest, has announced its dates for 2022! This unique, debate-style conference is also now complimentary for clinicians. Register today!

Imagine visiting the doctor, answering a few basic questions and getting an on-the-spot estimate of whether you'll experience heart failure in the next 30 years. Such a model now exists, thanks to a new Northwestern Medicine study, which...

Novartis today announced the US Food and Drug Administration (FDA) approval of Leqvio® (inclisiran), the first and only small interfering RNA (siRNA) therapy to lower low-density lipoprotein cholesterol (LDL-C) with two doses a year, after an...

AliveCor, the global leader in FDA-cleared personal electrocardiogram (ECG) technology, announced that KardiaMobile 6L, the most clinically-validated six-lead personal ECG device, is now available via KardiaPro on Epic's App Orchard...

First enrollment comes as investors provide $75M toward an oversubscribed Series C financing.

Algorithm reduces the volume of false positives from Medtronic implantable loop recorders by nearly 80% to boost medical staff productivity by focusing on meaningful cardiac arrhythmia events.

AtaCor Medical, Inc. announced that it has completed enrollment in its initial acute Extravascular Implantable Cardioverter Defibrillator (EV-ICD) study.

December 15, 2021 — People who suffer from both insomnia and obstructive sleep apnea are more likely to suffer from heart problems and are almost 50% more likely to die than those without either condition, say Flinders University researchers,...

The NEPTUNO study in secondary cardiovascular prevention, involving close to 6,500 patients, also highlights improved control of Cardiovascular Risk Factors and lower demand on healthcare resources than in control cohorts